MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Michael E. Castagna, Pharm.D.$1.1B
Market Cap • 25/04/20241991
(há 33 anos)
2004
(20 years ago)
NASDAQ
Listagem
Danbury
Sede • Connecticut395
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MNKDSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.